Symposium and Training at the IOZK: Immunotherapy in Neuro-Oncology, Friday, September 6, 2019
Immunotherapies have established themselves next to surgery, radiation, and chemotherapy over the last few years. The application of immunotherapy in neuro-oncology faces specific challenges, but is also show great promise.
On the occasion of opening its new GMP Laboratory, the IOZK will hold a scientific symposium with international speakers on the topic of “Immunotherapy in Neuro-Oncology”. We look forward to welcoming you.
Friday, September 6, 2019 | 10:00-18:00 | Steigenberger Hotel Köln | Habsburgerring 9-13 | 50674 Cologne
CME Points: 9 | The number of participants is limited. The fees for the symposium are 45,00 €.
Venues: Steigenberger Hotel Köln | Habsburgerring 9-13 | 50674 Cologne
GMP Laboratory: IOZK Immun-Onkologisches Zentrum Köln | Hohenstaufenring 30-32 | 50674 Cologne
To register, please complete the application form below and send it to us by fax, e-mail, or post.
Download application form (Pdf)
Scientific Program
09:30 Registration
Venue Steigenberger Hotel Köln
10:00-10:15 Welcome
Dr. Wilfried Stücker | CEO und Head of the IOZK Group | IOZK Immun-Onkologisches Zentrum Köln | Germany
10:15-10:45
Molecular detection of circulating tumor cells and characterization of therapy-related drug metabolizing genes
Dr. Lothar Prix | Laboratory diagnostics | LADR Laborzentrum Recklinghausen | Germany
10:45-11:15
Results against glioblastoma by Sitoiganap
Prof. Dr. Apostolos Stathopoulos | Chief Neurosurgeon | Euroclinic | Athens, Greece
11:15-11:45
Future developments of brain tumor vaccines
Prof. Dr. Matthias Eyrich | Pediatric Clinic | University Hospital Würzburg | Germany
11:45-12:15
Multimodal immunotherapy at IOZK
Stefaan Van Gool MD. PhD. | Translational Oncology | IOZK Immun-Onkologisches Zentrum Köln | Germany
12:15-14:15
Lunch and guided tour of the IOZK Clinical Unit and the IOZK GMP Laboratory
Venue: IOZK Center | Immun-Onkologisches Zentrum Köln | Hohenstaufenring 30–32, 50674 Cologne
14:15-14:45
Immuno-radiotherapy to prevent brain metastases from lung cancer
Prof. Dr. Dirk de Ruysscher | Radiation Oncologist | Maastricht University | The Netherlands
14:45-15:15
GlioVax: Dendritic cell vaccination therapy of glioblastoma
PD Dr. Rüdiger Sorg | Institute of Transplantation Diagnostics and Cell Therapeutics | Heinrich-Heine-University Düsseldorf | Germany
15:15-15:45
Oncolytic virus for pediatric brain tumors: from the bench to the clinic
Prof. Dr. Marta Alonso | Pediatric Clinic | Clinica Universidad Navarra | Pamplona, Spain
15:45-16:15 Coffee break
16:15-16:45
Update on clinical results from a cohort of GBM patients treated with autologous dendritic cells
Prof. Dr. Ricardo Díez Valle | Neurosurgery | Clinica Universidad Navarra | Pamplona, Spain
16:45-17:15
Immune monitoring of glioblastoma patients treated with dendritic cell immunotherapy
Prof. Dr. Serena Pellegatta | Molecular neuro-oncology | Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta | Milan, Italy
17:15-17:45
The Pan Tum Detect blood test (Apo10, TKTL1) and current immunophenotyping to monitor the response to immunotherapy
Dr. Oliver Feyen | Laboratory diagnostics | IOZK Immun-Onkologisches Zentrum Köln | Germany
17:45-18:00 Closing remarks
Dr. Wilfried Stücker | CEO und Head of the IOZK Group | IOZK Immun-Onkologisches Zentrum Köln | Germany
